An interventional study of Mechanical Diagnosis and Therapy (MDT) and Generalized Exercise in Chronic Spinal Pain, sponsored by Claus Kjærgaard. Not yet recruiting at 1 site in Denmark. Open to participants aged 25 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-03-20.
Sponsored by Claus Kjærgaard · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 90 studies in Chronic Pain with a site in Denmark — 14 open to participants now, 16 under way, none of them phase 3. Chronic Pain · Denmark.
Among the 90 studies in Chronic Pain with a site in Denmark, this one is the 31st largest by planned enrollment of the 57 interventional ones that give a count, is one of 5 that started in 2026, is one of 37 with no phase, reaches primary completion later than 10 of the 15 other live ones, and was the 87th registered.
3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.
Browse Chronic Pain studies →14 of the 90 studies in Chronic Pain with a site in Denmark are open now. Recruiting first, the newest first:
Vejle Hospital · Sites in Denmark
Ages 18–70
Vejle Hospital · Sites in Denmark
Ages 18–70
Aalborg University · Sites in Denmark
Ages 18–80
University of Aarhus · Sites in Denmark
Ages 18+
Zealand University Hospital · Sites in Denmark
Ages 18+
A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →
Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.
This study: 25 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
90 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 6 · Phase 3 9 · Phase 4 6
First in 2005; this study’s year is marked. 5 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 62 is close to the median of 60 across 2,388 interventional studies indexed under Chronic Pain.
Median enrollment 71 across the 57 interventional studies, 134 across the 33 observational. Of the 65 that completed or were terminated, 6 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 90 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Claus Kjærgaard as lead sponsor.
Claus Kjærgaard has 1 study filed under Chronic Pain — fewer than ten, so there is no comparison to draw.
3 of the studies in Chronic Pain with a site in Denmark that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07180407Zealand University HospitalThe Post-ICU Pain Study | 2027-01 |
| NCT07266103Aalborg UniversityMechanistic Study of Personalized rTMS in Chronic Pain | 2027-06-30 |
| NCT07293130Claus KjærgaardProtocol for a Randomized Controlled Trial Comparing the Effectiveness of Mechanical Diagnosis and Therapy Versus Generalized Exercise for Reducing Pain in Surgeons With Chronic Spinal Pain | 2027-09 |
Add all 3 to your calendar (.ics) → With an account.
Among the 90 studies in Chronic Pain with a site in Denmark, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Surgeons frequently experience chronic spinal pain due to prolonged static postures and repetitive movements during surgical procedures. Exercise therapy is recommended, but it is unclear which type of exercise is most effective for this population.
This randomized clinical trial will compare Mechanical Diagnosis and Therapy (MDT), also known as the McKenzie Method, with a structured program of generalized exercise in surgeons with chronic spinal pain who demonstrate a directional preference (i.e., movement in a specific direction that reduces symptoms).
Participants will be randomly assigned to one of the two interventions and followed for 26 weeks. The primary outcome is spinal pain intensity at 12 weeks measured on a 0-10 scale. Secondary outcomes include function, quality of life, and psychological factors.
This pragmatic trial is conducted in outpatient physiotherapy settings and aims to determine whether an individualized exercise approach (MDT) is more effective than generalized exercise in this occupational group.
Chronic spinal pain is common among surgeons due to prolonged static postures and physical demands during surgical procedures. Exercise therapy is recommended as first-line treatment, but the relative effectiveness of different exercise approaches remains unclear.
This study is a pragmatic, randomized, parallel-group trial comparing Mechanical Diagnosis and Therapy (MDT) with generalized exercise in surgeons with chronic spinal pain who demonstrate a directional preference. MDT is a classification-based approach that prescribes exercises based on symptom response to repeated movements, whereas generalized exercise includes strengthening, stretching, and endurance training without targeting directional preference.
Participants will be recruited from surgical specialties in Denmark and randomized 1:1 to MDT or generalized exercise. Interventions will be delivered by physiotherapists in outpatient clinical settings.
The primary objective is to compare the effect of MDT versus generalized exercise on spinal pain intensity at 12 weeks. Secondary objectives include effects on function, quality of life, and psychological factors.
The trial is designed to reflect routine clinical practice and to evaluate whether an individualized, classification-based exercise approach provides additional benefit compared with a guideline-based generalized exercise program.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Individualized exercise-based rehabilitation delivered according to the Mechanical Diagnosis and Therapy (MDT) approach. Treatment is based on a standardized assessment to identify directional preference, with exercises prescribed accordingly. Participants receive education, self-management advice, and ergonomic guidance relevant to their work. Up to six physiotherapy sessions are provided over 26 weeks, with home exercises prescribed and progressed between visits.
Behavioral: Mechanical Diagnosis and Therapy (MDT)
Non-direction-specific, guideline-based exercise rehabilitation for chronic spinal pain. The program includes strengthening, flexibility, and endurance exercises tailored to the individual but not based on directional preference. Participants receive education, self-management advice, and ergonomic guidance. Up to six physiotherapy sessions are provided over 26 weeks, with home exercises prescribed and progressed between visits.
Behavioral: Generalized Exercise
A classification-based physiotherapy intervention in which exercises are prescribed based on the individual's directional preference identified during assessment. Treatment includes repeated movements and/or sustained positions, supported by education and advice to promote self-management. Delivered by physiotherapists trained in MDT.
A structured exercise program including strengthening, stretching, and endurance training, adapted to the individual's symptoms and capacity. The intervention does not target directional preference and reflects usual physiotherapy care for chronic spinal pain. Delivered by physiotherapists experienced in musculoskeletal rehabilitation.
Average spinal pain intensity
Average spinal pain intensity over the preceding seven days measured using the Numeric Pain Rating Scale (0-10), where higher scores indicate greater pain. The primary analysis will compare the between-group difference at 12 weeks, adjusted for baseline pain intensity.
Time frame: 12 weeks
Patient-Specific Functional Scale
Patient-Specific Functional Scale (PSFS). Self-reported functional limitations assessed on a scale from 0 to 10 for each activity, where 0 indicates inability to perform the activity and 10 indicates ability to perform at the pre-injury level. Higher scores indicate better function. Total score will be analyzed as change from baseline by group mean.
Time frame: Baseline, 4 weeks, 12 weeks, 26 weeks
Short Form-12
Short Form-12 Health Survey (SF-12). Health-related quality of life assessed using Physical Component Summary (PCS) and Mental Component Summary (MCS) scores, each ranging from 0 to 100, where higher scores indicate better health status. Scores will be analyzed as change from baseline by group mean.
Time frame: Baseline, 4 weeks, 12 weeks, 26 weeks
Fear-Avoidance Beliefs Questionnaire
Fear-Avoidance Beliefs Questionnaire (FABQ). Fear of movement and work-related beliefs assessed on a scale from 0 to 96, where higher scores indicate greater fear-avoidance beliefs. Total score will be analyzed as change from baseline by group mean.
Time frame: Baseline, 4 weeks, 12 weeks, 26 weeks
Pain Catastrophizing Scale
Pain Catastrophizing Scale (PCS). Pain catastrophizing assessed on a scale from 0 to 52, where higher scores indicate greater catastrophizing. Total score will be analyzed as change from baseline by group mean.
Time frame: Baseline, 4 weeks, 12 weeks, 26 weeks
Pain Self-Efficacy Questionnaire
Pain Self-Efficacy Questionnaire (PSEQ). Pain self-efficacy assessed on a scale from 0 to 60, where higher scores indicate greater confidence in performing activities despite pain. Total score will be analyzed as change from baseline by group mean.
Time frame: Baseline, 4 weeks, 12 weeks, 26 weeks
Working Alliance Inventory
Working Alliance Inventory (WAI). Therapeutic alliance assessed on a scale from 12 to 84, where higher scores indicate stronger therapeutic alliance. Total score will be analyzed as change from prior assessment by group mean.
Time frame: 4 weeks, 12 weeks, 26 weeks (no baseline)
Exercise Adherence Rating Scale
Exercise Adherence Rating Scale (EARS). Exercise adherence assessed on a scale from 0 to 24, where higher scores indicate greater adherence to prescribed exercise. Total score will be analyzed as change from prior assessment by group mean.
Time frame: 4 weeks, 12 weeks, 26 weeks (no baseline)
Patient Global Impression of Change
Patient Global Impression of Change (PGIC). Patient-rated global improvement assessed on a 7-point scale from 1 (very much improved) to 7 (very much worse), where lower scores indicate greater improvement. Scores will be summarized by group at each follow-up.
Time frame: 4 weeks, 12 weeks, 26 weeks (no baseline)
Plan to share: Yes — De-identified individual participant data underlying published results (text, tables, figures, appendices) will be made available no earlier than 12 months after publication of the primary results and for up to 5 years. Access will be granted for academic purposes to qualified researchers upon reasonable request and approval by the Principal Investigator. Data sharing will require a formal application and a data use agreement, and data will be provided through secure transfer.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code
Time frame: De-identified individual participant data and supporting documents will be available beginning 6 months after publication of trial results and remain available for 5 years.
Access criteria: Data will be shared with qualified researchers for academic purposes only. Access requires submission of a reasonable request and a formal application to the Principal Investigator. Approved applicants will receive de-identified data and supporting materials through secure data transfer.
Data sharing details ↗ · vbn.aau.dk
Start is estimated for Mar 2026; primary completion for Sep 2027, 18 months later.
Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 18 months is close to that.
Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.